Hisamitsu Pharmaceutical Correlations

HPX Stock

EUR 23.20 0.40 1.75%

The current 90-days correlation between Hisamitsu Pharmaceutical and LG Display Co is 0.24 (i.e., Modest diversification). The correlation of Hisamitsu Pharmaceutical is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Hisamitsu Pharmaceutical Correlation With Market

Significant diversification

The correlation between Hisamitsu Pharmaceutical Co and DJI is 0.01 (i.e., Significant diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Hisamitsu Pharmaceutical Co and DJI in the same portfolio, assuming nothing else is changed.

The ability to find closely correlated positions to Hisamitsu Pharmaceutical could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Hisamitsu Pharmaceutical when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Hisamitsu Pharmaceutical - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Hisamitsu Pharmaceutical Co to buy it.

Moving together with Hisamitsu Stock

0.64	MRK	Merck Company	Pair Corr
0.67	GU5	Guangzhou Baiyunshan	Pair Corr
0.64	LDZU	ASPEN PHARUNADR 1	Pair Corr
0.69	KWE1	Ring Energy	Pair Corr

Moving against Hisamitsu Stock

0.94	VP3	VIETNAM ENTERPRISE INV	Pair Corr
0.86	FA2	FORWARD AIR P	Pair Corr
0.86	2C6	China Development Bank	Pair Corr
0.83	3KY	HANSOH PHARMAC HD	Pair Corr
0.81	74G	DIVIDEND GROWTH SPLIT	Pair Corr
0.69	AG8	AGILENT TECH	Pair Corr
0.66	JOT	ELEKTROBIT	Pair Corr
0.61	CJH	CanSino Biologics	Pair Corr
0.53	WOF	Wolford Aktiengesellscha	Pair Corr
0.43	LIE	Sun Life Financial	Pair Corr
0.36	AI3A	Amadeus IT Group	Pair Corr
0.84	HEI	Heidelberg Materials	Pair Corr
0.84	KOM1	Komatsu	Pair Corr
0.82	PZXB	PING AN INSURANCH	Pair Corr
0.79	KGHA	KGHM Polska Miedz	Pair Corr
0.75	E908	Lyxor 1	Pair Corr
0.69	RHM	Rheinmetall AG	Pair Corr
0.69	DBPE	Xtrackers LevDAX	Pair Corr
0.68	1W3	WSP Global	Pair Corr
0.65	F1YN	Lundin Gold	Pair Corr
0.57	SEBC	Skandinaviska Enskilda	Pair Corr
0.51	TDK	TDK Corporation	Pair Corr
0.51	TGE1	Mobilezone Holding	Pair Corr
0.48	2BH	HCA Healthcare Earnings Call This Week	Pair Corr
0.46	T1I	Tamburi Investment	Pair Corr
0.39	RAX	RANGE RESOURCES Earnings Call Tomorrow	Pair Corr
0.39	DSG	DICKS Sporting Goods	Pair Corr

Related Correlations Analysis

	KEC	9GY	LGA	2GL	HKT	ML2	SNF	UVD
KEC		0.56	0.33	-0.05	0.7	0.0	0.43	0.31	KEC
9GY	0.56		0.76	-0.41	0.67	0.0	0.77	0.57	9GY
LGA	0.33	0.76		-0.51	0.58	0.0	0.89	0.85	LGA
2GL	-0.05	-0.41	-0.51		-0.39	0.0	-0.61	-0.62	2GL
HKT	0.7	0.67	0.58	-0.39		0.0	0.78	0.68	HKT
ML2	0.0	0.0	0.0	0.0	0.0		0.0	0.0	ML2
SNF	0.43	0.77	0.89	-0.61	0.78	0.0		0.85	SNF
UVD	0.31	0.57	0.85	-0.62	0.68	0.0	0.85		UVD
	KEC	9GY	LGA	2GL	HKT	ML2	SNF	UVD

Click cells to compare fundamentals

Check Volatility

Backtest Portfolio

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.

High positive correlations

SNF	+ 0.89	LGA
UVD	+ 0.85	LGA
UVD	+ 0.85	SNF
SNF	+ 0.78	HKT
SNF	+ 0.77	9GY
LGA	+ 0.76	9GY

High negative correlations

UVD	- 0.62	2GL
SNF	- 0.61	2GL
2GL	- 0.51	LGA
2GL	- 0.41	9GY
HKT	- 0.39	2GL
2GL	- 0.05	KEC

Risk-Adjusted Indicators

There is a big difference between Hisamitsu Stock performing well and Hisamitsu Pharmaceutical Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Hisamitsu Pharmaceutical's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

	Mean Deviation	Jensen Alpha	Sortino Ratio	Treynor Ratio	Semi Deviation	Expected Shortfall	Potential Upside	Value @Risk	Maximum Drawdown
KEC	2.77	0.51	0.03	(0.59)	3.57	(6.14)	4.76	(8.00)	33.57
9GY	2.61	0.90	0.31	2.70	1.60	(4.40)	6.56	(3.60)	24.72
LGA	1.69	0.25	0.06	(3.39)	1.76	(1.89)	4.26	(2.92)	9.12
2GL	0.99	0.02	0.00	0.07	0.00	0.00	2.17	(2.08)	5.94
HKT	0.96	0.21	0.04	(1.83)	0.76	(1.79)	1.67	(1.61)	5.11
ML2	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
SNF	2.39	0.81	0.29	(6.41)	1.61	(2.89)	4.73	(3.82)	34.81
UVD	1.66	0.38	0.17	4.10	1.28	(2.04)	3.31	(2.46)	16.45

Be your own money manager

Our tools can tell you how much better you can do entering a position in Hisamitsu Pharmaceutical without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Investing Opportunities Now

Investing Opportunities

Build portfolios using our predefined set of ideas and optimize them against your investing preferences

All Next

Launch Module

Hisamitsu Pharmaceutical Corporate Management

Elected by the shareholders, the Hisamitsu Pharmaceutical's board of directors comprises two types of representatives: Hisamitsu Pharmaceutical inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Hisamitsu. The board's role is to monitor Hisamitsu Pharmaceutical's management team and ensure that shareholders' interests are well served. Hisamitsu Pharmaceutical's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Hisamitsu Pharmaceutical's outside directors are responsible for providing unbiased perspectives on the board's policies.

Kyu Saito	Head Officer	Profile
Shinichiro Takao	Head MD	Profile
Mitsutoshi Tsuruta	Ex Division	Profile
Masaya Okuno	OTC Division	Profile
Kazuhide Nakatomi	CEO Pres	Profile
Koji Takiyama	Sr Director	Profile
Kosuke Sugiyama	Exec MD	Profile

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2025 Macroaxis LLC